thymidine has been researched along with stavudine in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (12.12) | 18.7374 |
1990's | 11 (16.67) | 18.2507 |
2000's | 36 (54.55) | 29.6817 |
2010's | 11 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horwitz, JP; Kessel, D; Meltsner, BR; Palomino, E | 1 |
Baba, M; Balzarini, J; Broder, S; De Clercq, E; Herdewijn, P; Pauwels, R; Vanderhaeghe, H | 1 |
Li, Y; Liotta, DC; Liu, L; Lutz, S; Soni, PB; Zhang, X | 1 |
Eguchi, S; Hamano, Y; Matsuoka, Y; Minamoto, K; Watanabe, K | 1 |
August, EM; Birks, EM; Prusoff, WH | 1 |
August, EM; Marongiu, ME; Prusoff, WH | 1 |
Lin, TS; Prusoff, WH; Schinazi, RF | 1 |
August, EM; Brankovan, V; Ghazzouli, I; Hitchcock, MJ; Lin, TS; Mansuri, MM; Prusoff, WH; Sommadossi, JP; Starrett, JE; Sterzycki, RZ | 1 |
Balzarini, J; De Clercq, E; Herdewijn, P | 1 |
Schmahl, W; Stammberger, I; Tempel, K | 1 |
Domin, BA; Mahony, WB; Zimmerman, TP | 1 |
Baba, M; De Clercq, E; Desmyter, J; Herdewijn, P; Pauwels, R; Vandeputte, M | 1 |
Hamamoto, Y; Matsuda, A; Matsui, T; Nakashima, H; Ueda, T; Yamamoto, N | 1 |
Bawdon, RE; Kaul, S; Sobhi, S | 1 |
Balzarini, J | 1 |
Sinko, PJ; Waclawski, AP | 1 |
Baba, M; Hashimoto, KI; Okamoto, M; Shigeta, S; Tsunoda, R | 1 |
Back, DJ; Barry, MG; Hoggard, PG; Kewn, S; Khoo, SH | 1 |
Segal, MB; Thomas, SA | 1 |
Balzarini, J; Camarasa, MJ; Chamorro, C; De Clercq, E; Jimeno, ML; Tuñón, V; Velázquez, S | 1 |
Boretto, J; Canard, B; Deville-Bonne, D; Guerreiro, C; Janin, J; Meyer, P; Sarfati, S; Schneider, B; Véron, M | 1 |
Kong, F; Ning, J | 1 |
Agut, H; Angleraud, F; Bonmarchand, M; Brun-Vezinet, F; Calvez, V; Coutellier, A; Delaugerre, C; Descamps, D; Izopet, J; Katlama, C; Matheron, S; Mouroux, M; Valantin, MA; Yvon-Groussin, A | 1 |
Clark, R; Cohen, C; Cooley, T; Grosso, R; Gulick, R; Marlowe, SI; Mauney, J; Mulanovich, V; Santana, J; Schoellkopf, N; Squires, KE; Stevens, M; Tebas, P; Uffelman, K; Wright, D; Yangco, B | 1 |
Bellos, N; Eron, JJ; Esinhart, J; Grosso, R; Jemsek, J; Murphy, RL; Parenti, DM; Peterson, D; Pottage, J; Rashbaum, BC; Schoellkopf, N; Sepulveda, G; Stevens, M; Swindells, S | 1 |
Bower, M; Gazzard, BG; Mandalia, S; Matthews, GV; Moyle, GJ; Nelson, M | 1 |
Aquaro, S; Balzarini, J; Bianchi, V; De Clercq, E; Knispel, T; Meier, C; Perno, CF; Rampazzo, C | 1 |
Becker, SL; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Igboko, EF; Raffanti, SR; Slatko, GH | 1 |
Becker, S; Fisher, R; Graham, N; Henry, K; Hernandez, J; Hirani, A; Liao, Q; Raffanti, S; Ross, L; Scarsella, A; St Clair, M | 1 |
Ait-Khaled, M; Amphlett, G; Clotet, B; Katlama, C; Staszewski, S; Stone, C; Tisdale, M | 1 |
Balzarini, J; De Clercq, E; Meier, C; Muus, U; Naesens, L; Renze, J | 1 |
Balzarini, J; De Clercq, E; Ducho, C; Meier, C; Naesens, L | 1 |
Pendergrass, S; Qazi, S; Richman, D; Uckun, FM; Venkatachalam, TK | 1 |
Bates, M; Hellmann, NS; Hughes, MD; Katzenstein, DA; Shafer, RW; Shulman, NS; Whitcomb, JM; Winters, MA; Zolopa, AR | 1 |
Carr, A; Cooper, DA; Hoy, J; Hudson, J; Law, M; Martin, A; Smith, DE | 1 |
Konrad, M; Lavie, A; Meier, C; Monnerjahn, C; Ostermann, N; Segura-Peña, D; Veit, T | 1 |
Balzarini, J; Barchi, JJ; Boyer, PL; Choi, Y; Comin, MJ; George, C; Hughes, SH; Jacobson, KA; Kim, HS; Marquez, VE; Mitsuya, H | 1 |
Bölske, G; Carnrot, C; Eriksson, S; Wang, L; Wehelie, R | 1 |
Calvez, V; Delaugerre, C; Katlama, C; Marcelin, AG; Simon, A; Viegas, P; Wirden, M | 1 |
Ajana, F; Alcaraz, I; Bocket, L; Gerard, Y; Goffard, A; Mouton, Y; Viget, N; Wattré, P; Yazdanpanah, Y | 1 |
Franco, S; Martínez, MA; Mas, A; Matamoros, T; Menéndez-Arias, L; Vázquez-Alvarez, BM | 1 |
Calvo, KC; Koser, GF; Wang, X | 1 |
Baba, M; Cheng, YC; Dutschman, GE; Haraguchi, K; Honma, Y; Itoh, Y; Nitanda, T; Takeda, S; Tanaka, H | 1 |
Bates, M; Chappey, C; Clair, MS; Fisher, R; Lanier, ER; Parkin, N; Ross, L; Tisdale, M | 1 |
Canard, B; Deval, J; Guerreiro, C; Matamoros, T; Menéndez-Arias, L; Mulard, L | 1 |
Borderi, M | 1 |
Kiseleva, IaIu; Pliasunova, OA; Pokrovskaia, NV; Pokrovskiĭ, AG | 1 |
Haraguchi, K; Sumino, M; Tanaka, H | 1 |
Haraguchi, K; Sumino, M; Takeda, S; Tanaka, H | 1 |
Balzarini, J; Gisch, N; Meier, C | 1 |
Côté, HC; Gadawski, I; Papp, E | 1 |
Bélec, L; Charpentier, C; Karmochkine, M; Laureillard, D; Piketty, C; Si-Mohamed, A; Sodqi, M; Weiss, L | 1 |
de la Fuente, M; Iza, N; Navarro, R; Palafox, MA | 1 |
Portilla, J | 1 |
Baba, M; Cheng, YC; Tanaka, H; Wang, X | 1 |
Martínez, MA; Matamoros, T; Menéndez-Arias, L; Nevot, M | 1 |
Alcolea Palafox, M; Iza, N | 1 |
Laclair, DD; McKee, EE; Morris, GW | 1 |
Curran, A; Ribera, E | 1 |
McCann, KA; McKee, EE; Williams, DW | 1 |
Bauerfeind, R; Behrens, GM; Binz, A; Leverkus, M; Panayotova-Dimitrova, D; Stankov, MV; Vondran, FW | 1 |
Chaiwarith, R; Kotarathitithum, W; Nuntachit, N; Praparattanapan, J; Sirisanthana, T; Supparatpinyo, K | 1 |
Flint, OP; Wang, F | 1 |
Badia, R; Ballana, E; Clotet, B; Esté, JA; Martí, R; Pauls, E; Riveira-Muñoz, E; Ruiz, A; Terradas, G; Torres-Torronteras, J | 1 |
Ba, S; Gottlieb, GS; Leong, SS; Oakes, MK; Parker, KM; Raugi, DN; Seydi, M; Smith, RA; Sow, PS; Wu, VH | 1 |
Kitabatake, A; Koide, Y; Suzuki, T | 1 |
4 review(s) available for thymidine and stavudine
Article | Year |
---|---|
Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
Topics: Animals; Antiviral Agents; Dideoxyadenosine; Dideoxynucleosides; Humans; Lamivudine; Purines; Pyrimidines; Retroviridae; Spiro Compounds; Stavudine; Thymidine; Uridine; Zalcitabine; Zidovudine | 1994 |
[Use of thymidine-sparing regimens in first-line therapy and in switches from thymidine analogues].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Stavudine; Thymidine; Treatment Outcome; Zidovudine | 2005 |
[Tenofovir as a strategy to avoid or limit adverse effects].
Topics: Adenine; Anemia; Anti-HIV Agents; Antimetabolites; Clinical Trials as Topic; DNA, Mitochondrial; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Glucose Metabolism Disorders; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Multicenter Studies as Topic; Organophosphonates; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Thymidine; Zidovudine | 2008 |
From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.
Topics: Adenine; Adipose Tissue; Body Composition; Dideoxynucleosides; Drug Substitution; Humans; Metabolism; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Thymidine; Zidovudine | 2011 |
6 trial(s) available for thymidine and stavudine
Article | Year |
---|---|
A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Zidovudine | 2000 |
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Dideoxynucleosides; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Viral Load; Zidovudine | 2000 |
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Homosexuality; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; White People; Zidovudine | 2001 |
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.
Topics: Adult; Anti-HIV Agents; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Phenotype; Predictive Value of Tests; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2002 |
Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.
Topics: Anti-HIV Agents; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Stavudine; Substance Withdrawal Syndrome; Thymidine; Zidovudine | 2002 |
Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Resistance, Multiple, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mutation; Stavudine; Thymidine; Viral Load; Zidovudine | 2004 |
56 other study(ies) available for thymidine and stavudine
Article | Year |
---|---|
Synthesis and in vitro evaluation of some modified 4-thiopyrimidine nucleosides for prevention or reversal of AIDS-associated neurological disorders.
Topics: AIDS Dementia Complex; Animals; Antiviral Agents; Cell Line; Chemical Phenomena; Chemistry; Chemistry, Physical; Cytopathogenic Effect, Viral; Dideoxynucleosides; HIV; Humans; Kinetics; Molecular Structure; Phosphorylation; Pyrimidine Nucleosides; Rabbits; Stavudine; T-Lymphocytes; Thymidine Kinase; Thymus Gland; Zidovudine | 1990 |
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.
Topics: Antiviral Agents; Cell Line; Chemical Phenomena; Chemistry; Cytopathogenic Effect, Viral; Deoxyribonucleosides; HIV; Humans; Structure-Activity Relationship; T-Lymphocytes; Virus Replication | 1987 |
Synthesis of fluorescent nucleoside analogs as probes for 2'-deoxyribonucleoside kinases.
Topics: Animals; Drosophila melanogaster; Fluorescent Dyes; Nucleosides; Phosphotransferases (Alcohol Group Acceptor) | 2010 |
Synthesis and reactivities of 2,2'-anhydro-1-(3'-deoxy-3'-iodo-5'-O-trityl- beta-D-arabinofuranosyl)thymine.
Topics: Dideoxynucleosides; Molecular Structure; Stavudine; Thymidine | 1991 |
3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.
Topics: Antiviral Agents; Cell Membrane Permeability; Cells, Cultured; Dideoxynucleosides; Diffusion; Dipyridamole; Humans; Kinetics; Lymphocytes; Octanols; Solubility; Stavudine; Thioinosine; Thymidine; Time Factors; Water | 1991 |
Effect of 3'-deoxythymidin-2'-ene (d4T) on nucleoside metabolism in H9 cells.
Topics: Amino Acids; Cell Division; Cell Survival; Cells, Cultured; Cytidine; Deoxycytidine; Dideoxynucleosides; Humans; Nucleosides; Stavudine; Thymidine; Thymidine Kinase; Uridine | 1990 |
Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.
Topics: Antiviral Agents; Deoxycytidine; HIV; Humans; Monocytes; Retroviridae Proteins; RNA-Directed DNA Polymerase; Stavudine; Thymidine; Virus Replication; Zidovudine | 1987 |
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent.
Topics: Antiviral Agents; Bone Marrow; Dideoxynucleosides; HIV; Stavudine; Thymidine; Zidovudine | 1989 |
Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Deoxycytidine; Deoxyribonucleotides; Dideoxynucleosides; Dose-Response Relationship, Drug; HIV; Humans; Mice; Phosphorylation; Sarcoma Viruses, Murine; Solubility; Stavudine; Thymidine; Zidovudine | 1989 |
Scheduled and unscheduled DNA synthesis in chick embryo liver following X-irradiation and treatment with DNA repair inhibitors in vivo.
Topics: Animals; Autoradiography; Chick Embryo; Cytarabine; Dideoxynucleosides; DNA; DNA Repair; In Vitro Techniques; Liver; Stavudine; Thymidine; Tritium | 1989 |
2',3'-Dideoxythymidine permeation of the human erythrocyte membrane by nonfacilitated diffusion.
Topics: Antiviral Agents; Biological Transport; Diffusion; Erythrocyte Membrane; Humans; Kinetics; Nucleosides; Stavudine; Thymidine; Tritium | 1988 |
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
Topics: Antigens, Viral; Antiviral Agents; Cell Line; Cell Survival; Cytopathogenic Effect, Viral; Dideoxynucleosides; HIV; Humans; Stavudine; Structure-Activity Relationship; Thymidine; Virus Replication; Zidovudine | 1987 |
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Topics: Antigens, Viral; Antiviral Agents; Cells, Cultured; Cytopathogenic Effect, Viral; Dideoxynucleosides; HIV; Humans; Stavudine; Thymidine; Viral Plaque Assay; Virus Replication; Zalcitabine; Zidovudine | 1987 |
The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placenta.
Topics: Diffusion; Dipyridamole; Female; Fetal Blood; Gestational Age; Humans; Maternal-Fetal Exchange; Perfusion; Placenta; Pregnancy; Stavudine; Thymidine; Zidovudine | 1994 |
Oral absorption of anti-acquired immune deficiency syndrome nucleoside analogues. 2. Carrier-mediated intestinal transport of stavudine in rat and rabbit preparations.
Topics: Administration, Oral; Animals; Antiviral Agents; Biological Availability; Biological Transport; Drug Carriers; Drug Stability; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Microvilli; Rabbits; Rats; Rats, Sprague-Dawley; Stavudine; Thymidine | 1996 |
Stavudine selectively induces apoptosis in HIV type 1-infected cells.
Topics: Anti-HIV Agents; Apoptosis; Cell Line; Didanosine; DNA Fragmentation; Down-Regulation; HIV Reverse Transcriptase; HIV-1; Humans; Nevirapine; Proto-Oncogene Proteins c-bcl-2; Pyridines; Reverse Transcriptase Inhibitors; Stavudine; T-Lymphocytes; Thymidine; Zalcitabine; Zidovudine | 1997 |
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.
Topics: Anti-HIV Agents; Cells, Cultured; Drug Interactions; Humans; Leukemia, Monocytic, Acute; Leukocytes, Mononuclear; Phosphorylation; Phytohemagglutinins; Stavudine; Stimulation, Chemical; Thymidine; Zidovudine | 1997 |
The transport of the anti-HIV drug, 2',3'-didehydro-3'-deoxythymidine (D4T), across the blood-brain and blood-cerebrospinal fluid barriers.
Topics: Analysis of Variance; Animals; Anti-HIV Agents; Biological Transport; Blood-Brain Barrier; Brain; Guinea Pigs; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Zidovudine | 1998 |
Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside region.
Topics: Anti-HIV Agents; Cell Line; Dimerization; HIV-1; HIV-2; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Fast Atom Bombardment; Spiro Compounds; Stavudine; Thymidine; Uridine; Zidovudine | 1999 |
Structural basis for activation of alpha-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase.
Topics: Anti-HIV Agents; Boron Compounds; Crystallography, X-Ray; DNA Repair; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Models, Molecular; Molecular Conformation; Nucleoside-Diphosphate Kinase; Protein Binding; Reverse Transcriptase Inhibitors; Stavudine; Structure-Activity Relationship; Thymidine; Transcription, Genetic; Zidovudine | 2000 |
A facile synthesis of 1-(5'-O-acetyl-3'-O-benzyl-beta-D-xylofuranosyl)thymidine: a potentially viable intermediate for the preparation of the anti-AIDS drugs, AZT and D4T.
Topics: Anti-HIV Agents; Stavudine; Thymidine; Zidovudine | 2000 |
[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T].
Topics: Anti-HIV Agents; Drug Resistance; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Zidovudine | 2000 |
Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Arteriosclerosis; Benzoxazines; Cholesterol; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Nevirapine; Oxazines; Risk Factors; Stavudine; Thymidine; Triglycerides; Zidovudine | 2000 |
Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine monophosphate: efficient intracellular delivery of d4TMP.
Topics: 5'-Nucleotidase; Anti-HIV Agents; Culture Media; Dideoxynucleotides; Half-Life; Humans; Hydrogen-Ion Concentration; Leukocytes, Mononuclear; Macrophages; Monocytes; Stavudine; Thymidine; Thymidine Kinase; Thymidine Monophosphate; Thymine Nucleotides; Time Factors; Tritium; Tumor Cells, Cultured; Zidovudine | 2000 |
Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Viremia; Zidovudine | 2001 |
M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine.
Topics: Drug Resistance, Microbial; Genotype; HIV Infections; HIV-1; Humans; Mutation; Phenotype; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Viral Load; Zidovudine | 2002 |
Comparative study of bis(benzyl)phosphate triesters of 2',3'-dideoxy-2',3'-didehydrothymidine (d4T) and cyclosal-d4TMP--hydrolysis, mechanistic insights and anti-HIV activity.
Topics: Anti-HIV Agents; Dideoxynucleotides; Esters; HIV-1; HIV-2; Humans; Hydrolysis; Molecular Structure; Stavudine; Structure-Activity Relationship; Thymidine; Thymidine Kinase; Thymine Nucleotides; Tumor Cells, Cultured | 2002 |
Aryl-substituted and benzo-annulated cyc/osal-derivatives of 2',3'-dideoxy-2',3'-didehydrothymidine monophosphate--correlation of structure, hydrolysis properties and anti-HIV activity.
Topics: Anti-HIV Agents; Dideoxynucleotides; Drug Stability; Esters; Half-Life; HIV-1; HIV-2; Humans; Hydrolysis; Kinetics; Nuclear Magnetic Resonance, Biomolecular; Stavudine; Structure-Activity Relationship; Thymidine; Thymidine Kinase; Thymine Nucleotides; Tumor Cells, Cultured | 2002 |
Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.
Topics: Anti-HIV Agents; Dideoxynucleotides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Nucleosides; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Structure-Activity Relationship; Thymidine; Thymidine Monophosphate; Zidovudine | 2002 |
Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compounds.
Topics: Anti-HIV Agents; Crystallography, X-Ray; Dideoxynucleotides; Drug Design; Humans; Kinetics; Macromolecular Substances; Nucleoside-Phosphate Kinase; Prodrugs; Protein Conformation; Stavudine; Structure-Activity Relationship; Substrate Specificity; Thymidine; Thymidine Monophosphate; Thymine Nucleotides | 2003 |
A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude.
Topics: Animals; Anti-HIV Agents; Bridged Bicyclo Compounds; Cell Line; Crystallography, X-Ray; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Lymphocytes; Molecular Conformation; Molecular Mimicry; Reverse Transcriptase Inhibitors; Stavudine; Stereoisomerism; Structure-Activity Relationship; Thymidine | 2003 |
Molecular characterization of thymidine kinase from Ureaplasma urealyticum: nucleoside analogues as potent inhibitors of mycoplasma growth.
Topics: Amino Acid Sequence; Cell Division; Cloning, Molecular; Deoxyuridine; Escherichia coli; Feedback, Physiological; Molecular Sequence Data; Molecular Weight; Mycoplasma pneumoniae; Nucleosides; Phosphates; Pyrimidine Nucleosides; Recombinant Proteins; Sequence Homology, Amino Acid; Stavudine; Substrate Specificity; Tetrahydrouridine; Thymidine; Thymidine Kinase; Thymine Nucleotides; Ureaplasma urealyticum; Zidovudine | 2003 |
Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure.
Topics: Anti-HIV Agents; Base Sequence; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thymidine; Treatment Failure; Viral Load; Zidovudine | 2004 |
Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA prim
Topics: Adenosine Triphosphate; Amino Acid Sequence; Base Sequence; Codon; DNA; DNA Primers; Drug Resistance, Viral; Gene Deletion; HIV Reverse Transcriptase; Kinetics; Models, Molecular; Molecular Sequence Data; Mutation; Peptides; Phenotype; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid; Stavudine; Thymidine; Time Factors; Tyrosine; Zidovudine | 2004 |
Bis-ketol nucleoside triesters as prodrugs of the antiviral nucleoside triphosphate analogues of 3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine.
Topics: Anti-HIV Agents; Cell Line; Esters; HIV; Humans; Molecular Structure; Nucleosides; Prodrugs; Stavudine; Thymidine | 2004 |
Synthesis and anti-HIV activity of 4'-cyano-2',3'-didehydro-3'-deoxythymidine.
Topics: Animals; Anti-HIV Agents; HIV Infections; HIV-1; Humans; Stavudine; Thymidine | 2004 |
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance.
Topics: Adenine; Algorithms; Anti-HIV Agents; Databases, Genetic; Didanosine; Dideoxynucleosides; Drug Resistance, Multiple, Viral; HIV; HIV Infections; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Thymidine; Zalcitabine; Zidovudine | 2004 |
Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by alpha-phosphate-modified thymidine analogues.
Topics: Adenosine Triphosphate; Boron Compounds; Dideoxynucleotides; Drug Resistance, Multiple, Viral; HIV-1; Humans; Kinetics; Mutation; Phosphorylation; RNA-Directed DNA Polymerase; Stavudine; Thymidine; Thymine Nucleotides; Time Factors; Zidovudine | 2005 |
[In vitro selection and phenotyping of HIV-1 mutants resistant to azidothymidine and didanosine].
Topics: Didanosine; Drug Resistance, Viral; HIV-1; Mutation; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Zidovudine | 2005 |
Nucleophilic substitution at the 4'-position of nucleosides: new access to a promising anti-HIV agent 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine.
Topics: Anti-HIV Agents; Indicators and Reagents; Nucleosides; Stavudine; Structure-Activity Relationship; Thymidine | 2006 |
An alternative method suitable for a large scale synthesis of 4'-ethynyl-2',3'-didehydro-3'-deoxythymidine.
Topics: Combinatorial Chemistry Techniques; Stavudine; Thymidine | 2004 |
Enzymatically activated cycloSal-d4T-monophosphates: The third generation of cycloSal-pronucleotides.
Topics: Anti-HIV Agents; Cell Line; Dideoxynucleotides; Humans; Hydrolysis; Organophosphates; Stavudine; Structure-Activity Relationship; Thymidine; Thymine Nucleotides | 2007 |
Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells.
Topics: Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA, Mitochondrial; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; K562 Cells; RNA; RNA, Mitochondrial; Stavudine; Thymidine; Time Factors; Zidovudine | 2008 |
Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Salvage Therapy; Stavudine; Thymidine; Treatment Outcome; Zidovudine | 2008 |
Simulation of the first hydration shell of nucleosides D4T and thymidine: structures obtained using MP2 and DFT methods.
Topics: Anti-HIV Agents; Hydrogen Bonding; Nucleic Acid Conformation; Quantum Theory; Stavudine; Thermodynamics; Thymidine; Water | 2009 |
Retention of metabolites of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel anti-human immunodeficiency virus type 1 thymidine analog, in cells.
Topics: Anti-HIV Agents; Biological Transport; Cell Line; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dipyridamole; Humans; Multidrug Resistance-Associated Proteins; Phosphodiesterase Inhibitors; Phosphorylation; Stavudine; Thymidine; Zidovudine | 2009 |
Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.
Topics: Acyclovir; Adenosine Triphosphate; Anti-HIV Agents; DNA Mutational Analysis; DNA Primers; Drug Resistance, Multiple; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Stavudine; Thymidine; Valine; Zidovudine | 2009 |
Tautomerism of the natural thymidine nucleoside and the antiviral analogue D4T. Structure and influence of an aqueous environment using MP2 and DFT methods.
Topics: Antiviral Agents; Hydrogen Bonding; Quantum Theory; Stavudine; Thermodynamics; Thymidine; Water | 2010 |
Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria.
Topics: Animals; Anti-HIV Agents; Deoxycytidine; Male; Mitochondria, Heart; Myocardium; Nucleosides; Perfusion; Phosphorylation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Stavudine; Thymidine; Zalcitabine; Zidovudine | 2010 |
Metabolism of deoxypyrimidines and deoxypyrimidine antiviral analogs in isolated brain mitochondria.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Deoxycytidine; Deoxyuridine; Dose-Response Relationship, Drug; Kinetics; Male; Mitochondria; Nucleotidases; Phosphorylation; Pyrimidine Nucleosides; Rats; Rats, Sprague-Dawley; Stavudine; Thymidine; Time Factors; Tritium; Zidovudine | 2012 |
Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation.
Topics: Anti-HIV Agents; Autophagy; Blotting, Western; Cells, Cultured; DNA, Mitochondrial; Fatty Liver; Female; Flow Cytometry; Hep G2 Cells; HIV Infections; Humans; Lipid Metabolism; Male; Microscopy, Electron; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Stavudine; Thymidine; Zidovudine | 2012 |
Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01_AE.
Topics: Adult; Aged; Anti-HIV Agents; Cohort Studies; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Thailand; Thymidine; Treatment Failure; Zidovudine | 2012 |
BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue.
Topics: Adenine; Adipocytes; DNA Fragmentation; DNA, Mitochondrial; Epithelial Cells; Humans; Kidney Tubules, Proximal; Mitochondria; Muscle Fibers, Skeletal; Organophosphonates; Primary Cell Culture; Reverse Transcriptase Inhibitors; Stavudine; Structure-Activity Relationship; Tenofovir; Thymidine | 2013 |
SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors.
Topics: CD4-Positive T-Lymphocytes; Gene Expression; HIV Reverse Transcriptase; HIV-2; Host-Pathogen Interactions; Humans; Jurkat Cells; Macrophages; Monomeric GTP-Binding Proteins; Primary Cell Culture; Reverse Transcriptase Inhibitors; SAM Domain and HD Domain-Containing Protein 1; Stavudine; Thymidine; Viral Regulatory and Accessory Proteins; Virus Replication; Zidovudine | 2014 |
The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Mutagenesis, Site-Directed; Protein Conformation; Reverse Transcriptase Inhibitors; Stavudine; Thymidine | 2015 |
Reaction of Thymidine with Hypobromous Acid in Phosphate Buffer.
Topics: Bromates; Buffers; Molecular Structure; Phosphates; Stavudine; Thymidine | 2016 |